GlassScriptPhysician profile
Erin Mccasland
NPI 1417416819
$3,116.16
in general payments reported to CMS, 2019-2025
22 companies · $930 in 2025
The $930 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.67 · 2022: $699 · 2023: $520 · 2024: $869 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,240 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,239.99 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,017.49 | 2021-2025 | Airsupra, Breztri, Tezspire |
| United Therapeutics Corporation | $516.36 | 2022-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $334.81 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Sanofi-Aventis U.S. LLC | $160.98 | 2022-2025 | |
| Glaxosmithkline, LLC. | $158.74 | 2021-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $144.29 | 2025 | Dupixent |
| Insmed, INC. | $110.04 | 2021-2024 | Arikayce |
| Grifols USA, LLC | $89.42 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $86.12 | 2023-2025 | Tezspire |
| Philips North America LLC | $72.62 | 2022-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $69.92 | 2022-2025 | |
| Verona Pharma, INC. | $51.68 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $46.46 | 2023-2024 | Acthar |
| Baxter Healthcare | $38.04 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $34.91 | 2024-2025 | Winrevair |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.37 | 2022-2023 | Ofev |
| Viatris Specialty LLC | $33.59 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $30.42 | 2022-2023 | Glassia |
| Inogen, INC. | $29.05 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Harmony Biosciences LLC | $22.95 | 2023 | Wakix |
| Medtronic, INC. | $17.17 | 2024 | Illumisite |
| Mylan Specialty L.P. | $16.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Mccasland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.